143 related articles for article (PubMed ID: 1379062)
1. Specific detection of c-erbB-2 mRNA expression in gastric cancers by the polymerase chain reaction following reverse transcription.
Ninomiya I; Endo Y; Yonemura Y; Noguchi M; Fushida S; Nakai M; Takamura H; Harada F; Suzuki T; Miyazaki I
Br J Cancer; 1992 Jul; 66(1):84-7. PubMed ID: 1379062
[TBL] [Abstract][Full Text] [Related]
2. Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer.
Lemoine NR; Jain S; Silvestre F; Lopes C; Hughes CM; McLelland E; Gullick WJ; Filipe MI
Br J Cancer; 1991 Jul; 64(1):79-83. PubMed ID: 1677259
[No Abstract] [Full Text] [Related]
3. c-erbB3 gene encodes secreted as well as transmembrane receptor tyrosine kinase.
Katoh M; Yazaki Y; Sugimura T; Terada M
Biochem Biophys Res Commun; 1993 May; 192(3):1189-97. PubMed ID: 7685162
[TBL] [Abstract][Full Text] [Related]
4. Ki-ras and c-myc oncogene expression measured by coamplification polymerase chain reaction.
Sugimoto T; Tsukamato F; Fujita M; Takai S
Biochem Biophys Res Commun; 1994 Jun; 201(2):574-80. PubMed ID: 8002989
[TBL] [Abstract][Full Text] [Related]
5. G to A polymorphism at amino acid codon 655 of the human erbB-2/HER2 gene.
Papewalis J; Nikitin AYu ; Rajewsky MF
Nucleic Acids Res; 1991 Oct; 19(19):5452. PubMed ID: 1681519
[No Abstract] [Full Text] [Related]
6. Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene.
Sikes RA; Chung LW
Cancer Res; 1992 Jun; 52(11):3174-81. PubMed ID: 1350510
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of hepatocyte growth factor and c-Met mRNAs in isografts in experimental rat liver transplants.
Ogasawara H; Tanabe M; Furuya T; Murase N; Iwatsuki S; Nakamura T; Katyal SL; Shinozuka H
Transplant Proc; 1993 Feb; 25(1 Pt 1):149-51. PubMed ID: 7679809
[No Abstract] [Full Text] [Related]
8. Alterations of the c-erbB2 gene in human breast cancer.
Zoll B; Kynast B; Corell B; Marx D; Fischer G; Schauer A
J Cancer Res Clin Oncol; 1992; 118(6):468-73. PubMed ID: 1352298
[TBL] [Abstract][Full Text] [Related]
9. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
10. Lack of rearranged Tpr-met mRNA expression in human gastric cancer cell lines and gastric mucosa and carcinoma.
Osaki M; Miyata H; Hayashi A; Gomyo Y; Tatebe S; Ito H
Anticancer Res; 1996; 16(5A):2881-4. PubMed ID: 8917402
[TBL] [Abstract][Full Text] [Related]
11. A polymorphic microsatellite repeat is located close to the promoter region of the c-fgr proto-oncogene (FGR) at chromosome 1p36.2-p36.1.
Patel MS; Mankoo BS; Brickell PM
Hum Mol Genet; 1992 Apr; 1(1):65. PubMed ID: 1339476
[No Abstract] [Full Text] [Related]
12. A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines.
Hollywood DP; Hurst HC
EMBO J; 1993 Jun; 12(6):2369-75. PubMed ID: 8099545
[TBL] [Abstract][Full Text] [Related]
13. Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides.
Bertram J; Killian M; Brysch W; Schlingensiepen KH; Kneba M
Biochem Biophys Res Commun; 1994 Apr; 200(1):661-7. PubMed ID: 7909438
[TBL] [Abstract][Full Text] [Related]
14. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2.
Deng G; Podack ER
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2189-93. PubMed ID: 8460122
[TBL] [Abstract][Full Text] [Related]
15. Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification.
Kameda T; Yasui W; Yoshida K; Tsujino T; Nakayama H; Ito M; Ito H; Tahara E
Cancer Res; 1990 Dec; 50(24):8002-9. PubMed ID: 1979253
[TBL] [Abstract][Full Text] [Related]
16. Co-amplification of c-myc and c-erbB-2 oncogenes in a poorly differentiated human gastric cancer.
Tsuchiya T; Ueyama Y; Tamaoki N; Yamaguchi S; Shibuya M
Jpn J Cancer Res; 1989 Oct; 80(10):920-3. PubMed ID: 2575609
[TBL] [Abstract][Full Text] [Related]
17. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.
Semba K; Kamata N; Toyoshima K; Yamamoto T
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6497-501. PubMed ID: 2995967
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of T-cell proliferation by a MYB antisense oligomer is accompanied by selective down-regulation of DNA polymerase alpha expression.
Venturelli D; Travali S; Calabretta B
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5963-7. PubMed ID: 1696013
[TBL] [Abstract][Full Text] [Related]
19. Expression of int-2 oncogene in Kaposi's sarcoma lesions.
Huang YQ; Li JJ; Moscatelli D; Basilico C; Nicolaides A; Zhang WG; Poiesz BJ; Friedman-Kien AE
J Clin Invest; 1993 Mar; 91(3):1191-7. PubMed ID: 8450048
[TBL] [Abstract][Full Text] [Related]
20. Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas.
Park JB; Rhim JS; Park SC; Kimm SW; Kraus MH
Cancer Res; 1989 Dec; 49(23):6605-9. PubMed ID: 2573419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
